Finance

Lists
4538:TYO
Fuso Pharmaceutical Industries Ltd
2 165,00 JPY
-1,86%
(-41,00) 1D
2 ოქტ, 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4538...
Open
2 192 JPY
High
2 192 JPY
Low
2 161 JPY
Mkt. cap
20,46 მლრდ.
Avg. vol.
13,68 ათ.
Volume
20,70 ათ.
Dividend
4,16%
Quarterly dividend
23 JPY
Ex-dividend date
29 სექ. 2026
P/E ratio
8,44
52-wk high
2 530 JPY
52-wk low
1 990 JPY
EPS
257 JPY
Shares outstanding
8,78 მლნ.
No. of employees
1 ათ.
Open
2 192 JPY
High
2 192 JPY
Low
2 161 JPY
Mkt. cap
20,46 მლრდ.
Avg. vol.
13,68 ათ.
Volume
20,70 ათ.
Dividend
4,16%
Quarterly dividend
23 JPY
Ex-dividend date
29 სექ. 2026
P/E ratio
8,44
52-wk high
2 530 JPY
52-wk low
1 990 JPY
EPS
257 JPY
Shares outstanding
8,78 მლნ.
No. of employees
1 ათ.
News stories
From web sources and news partners
Business Insider
Business Insider
·
1 საათის წინ
The NYSE's Most Famous Floor Trader Says AI Can't Take His Job
MarketBeat
MarketBeat
·
51 წუთის წინ
Roth Capital Upgrades Suja Life (NASDAQ:SUJA) to Strong-Buy
WSJ
WSJ
·
14 საათის წინ
Nasdaq Leads Stocks Higher as Hiring Softens
About Fuso Pharmaceutical Industries Ltd
CEO-
Employees1,37 ათ.
Founded25 მარ. 1937
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
15,73 მლრდ.
17,04 მლრდ.
14,04 მლრდ.
16,05 მლრდ.
Cost of goods sold
11,70 მლრდ.
12,62 მლრდ.
10,57 მლრდ.
11,85 მლრდ.
Cost of revenue
11,70 მლრდ.
12,62 მლრდ.
10,57 მლრდ.
11,85 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,38 მლრდ.
3,30 მლრდ.
3,20 მლრდ.
3,22 მლრდ.
Operating expense
3,38 მლრდ.
3,30 მლრდ.
3,20 მლრდ.
3,22 მლრდ.
Total operating expenses
15,08 მლრდ.
15,91 მლრდ.
13,77 მლრდ.
15,07 მლრდ.
Operating income
650,00 მლნ.
1,12 მლრდ.
272,00 მლნ.
973,00 მლნ.
Other non operating income
-110,00 მლნ.
-24,00 მლნ.
-40,00 მლნ.
-134,00 მლნ.
EBT including unusual items
456,00 მლნ.
1,20 მლრდ.
132,00 მლნ.
910,00 მლნ.
EBT excluding unusual items
478,00 მლნ.
1,08 მლრდ.
131,00 მლნ.
828,00 მლნ.
Income tax expense
87,00 მლნ.
350,00 მლნ.
-195,00 მლნ.
268,00 მლნ.
Effective tax rate
19,08%
29,09%
-147,73%
29,45%
Other operating expenses
-
-
-
-
Net income
369,00 მლნ.
853,00 მლნ.
327,00 მლნ.
642,00 მლნ.
Net profit margin
2,35%
5,01%
2,33%
4,00%
Earnings per share
-
-
-
-
Interest and investment income
14,00 მლნ.
67,00 მლნ.
1,00 მლნ.
93,00 მლნ.
Interest expense
-76,00 მლნ.
-80,00 მლნ.
-102,00 მლნ.
-104,00 მლნ.
Net interest expenses
-62,00 მლნ.
-13,00 მლნ.
-101,00 მლნ.
-11,00 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
1,30 მლრდ.
-
926,50 მლნ.
1,63 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები